Prediction of biochemical recurrence after robot-assisted radical prostatectomy: Analysis of 784 Japanese patients

被引:20
作者
Hashimoto, Takeshi [1 ]
Yoshioka, Kunihiko [1 ]
Nagao, Go [1 ]
Nakagami, Yoshihiro [1 ]
Ohno, Yoshio [1 ]
Horiguchi, Yutaka [1 ]
Namiki, Kazunori [1 ]
Nakashima, Jun [1 ]
Tachibana, Masaaki [1 ]
机构
[1] Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan
关键词
biochemical recurrence; pathological Gleason score; pathological Tstage; positive surgical margin; prostate-specific antigen density; MINIMUM FOLLOW-UP; CANCER; ANTIGEN; OUTCOMES; RISK; CARCINOMA; PATHOLOGY; SURVIVAL; DENSITY; COHORT;
D O I
10.1111/iju.12624
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo examine biochemical recurrence after robot-assisted radical prostatectomy in Japanese patients, and to develop a risk stratification model for biochemical recurrence. MethodsThe study cohort consisted of 784 patients with localized prostate cancer who underwent robot-assisted radical prostatectomy without neoadjuvant or adjuvant endocrine therapy. The relationships of biochemical recurrence with perioperative findings were evaluated. The prognostic factors for biochemical recurrence-free survival were evaluated using Cox proportional hazard model analyses. ResultsDuring the follow-up period, 80 patients showed biochemical recurrence. The biochemical recurrence-free survival rates at 1, 3, and 5 years were 92.2%, 85.2% and 80.1%, respectively. In univariate analysis, the prostate-specific antigen level, prostate-specific antigen density, biopsy Gleason score, percent positive core, pathological Tstage, pathological Gleason score, lymphovascular invasion, perineural invasion and positive surgical margin were significantly associated with biochemical recurrence. In multivariate analysis, prostate-specific antigen density 0.4 (P=0.0011), pathological Tstage 3a (P=0.002), pathological Gleason score 8 (P=0.007) and positive surgical margin (P<0.0001) were independent predictors of biochemical recurrence. The patients were stratified into three risk groups according to these factors. The 5-year biochemical recurrence-free survival rate was 89.4% in the low-risk group, 65.6% in the intermediate-risk group and 30.3% in the high-risk group. ConclusionsThe prostate-specific antigen density, pathological Tstage, pathological Gleason score and positive surgical margin were independent prognostic factors for biochemical recurrence. The risk stratification model developed using these four factors could help clinicians identify patients with a poor prognosis who might be good candidates for clinical trials of alternative management strategies.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 2021, JAP SOC RAD TECHN MA
[2]   Metastatic renal carcinoma comprehensive prognostic system [J].
Atzpodien, J ;
Royston, P ;
Wandert, T ;
Reitz, M .
BRITISH JOURNAL OF CANCER, 2003, 88 (03) :348-353
[3]   Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy [J].
Blute, ML ;
Bergstralh, EJ ;
Iocca, A ;
Scherer, B ;
Zincke, H .
JOURNAL OF UROLOGY, 2001, 165 (01) :119-125
[4]   Racial Differences in Trust and Regular Source of Patient Care and the Implications for Prostate Cancer Screening Use [J].
Carpenter, William R. ;
Godley, Paul A. ;
Clark, Jack A. ;
Talcott, James A. ;
Finnegan, Timothy ;
Mishel, Merle ;
Bensen, Jeannette ;
Rayford, Walter ;
Su, L. Joseph ;
Fontham, Elizabeth T. H. ;
Mohler, James L. .
CANCER, 2009, 115 (21) :5048-5059
[5]   International Variation in Prostate Cancer Incidence and Mortality Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Lortet-Tieulent, Joannie ;
Ward, Elizabeth ;
Ferlay, Jacques ;
Brawley, Otis ;
Bray, Freddie .
EUROPEAN UROLOGY, 2012, 61 (06) :1079-1092
[6]   Athermal early retrograde release of the neurovascular bundle during nerve-sparing robotic-assisted laparoscopic radical prostatectomy [J].
Coughlin G. ;
Dangle P.P. ;
Palmer K.J. ;
Samevedi S. ;
Patel V.R. .
Journal of Robotic Surgery, 2009, 3 (1) :13-17
[7]   Comparison of the clinical outcome after hormonal therapy for prostate cancer between Japanese and Caucasian men [J].
Fukagai, T ;
Namiki, TS ;
Carlile, RG ;
Yoshida, H ;
Namiki, M .
BJU INTERNATIONAL, 2006, 97 (06) :1190-1193
[8]   Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer [J].
Han, M ;
Partin, AW ;
Zahurak, M ;
Piantadosi, S ;
Epstein, JI ;
Walsh, PC .
JOURNAL OF UROLOGY, 2003, 169 (02) :517-523
[9]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[10]  
2-4